oxaloacetic acid has been researched along with Brain Ischemia in 6 studies
Oxaloacetic Acid: A dicarboxylic acid ketone that is an important metabolic intermediate of the CITRIC ACID CYCLE. It can be converted to ASPARTIC ACID by ASPARTATE TRANSAMINASE.
oxaloacetic acid : An oxodicarboxylic acid that is succinic acid bearing a single oxo group.
Brain Ischemia: Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pérez-Mato, M | 2 |
| Ramos-Cabrer, P | 3 |
| Sobrino, T | 3 |
| Blanco, M | 1 |
| Ruban, A | 1 |
| Mirelman, D | 1 |
| Menendez, P | 1 |
| Castillo, J | 3 |
| Campos, F | 3 |
| Knapp, L | 2 |
| Gellért, L | 1 |
| Kocsis, K | 2 |
| Kis, Z | 2 |
| Farkas, T | 2 |
| Vécsei, L | 2 |
| Toldi, J | 2 |
| Mészáros, J | 1 |
| Argibay, B | 1 |
| Agulla, J | 1 |
| Rodríguez-González, R | 1 |
| Brea, D | 1 |
| Frenzel, J | 1 |
| Richter, J | 1 |
| Eschrich, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Anhydrous Enol-Oxaloacetate (AEO) on Improving Fatigue in Post-COVID-19 Survivors[NCT04592354] | 40 participants (Anticipated) | Interventional | 2020-10-15 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for oxaloacetic acid and Brain Ischemia
| Article | Year |
|---|---|
Oxaloacetate: a novel neuroprotective for acute ischemic stroke.
Topics: Animals; Brain; Brain Ischemia; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Nerve Dege | 2012 |
5 other studies available for oxaloacetic acid and Brain Ischemia
| Article | Year |
|---|---|
Human recombinant glutamate oxaloacetate transaminase 1 (GOT1) supplemented with oxaloacetate induces a protective effect after cerebral ischemia.
Topics: Animals; Aspartate Aminotransferase, Cytoplasmic; Brain; Brain Ischemia; Disease Models, Animal; Hum | 2014 |
Neuroprotective effect of oxaloacetate in a focal brain ischemic model in the rat.
Topics: Animals; Brain Ischemia; Disease Models, Animal; Male; Neuroprotective Agents; Oxaloacetic Acid; Rat | 2015 |
Acetyl-L-carnitine and oxaloacetate in post-treatment against LTP impairment in a rat ischemia model. An in vitro electrophysiological study.
Topics: Acetylcarnitine; Animals; Brain Ischemia; Disease Models, Animal; Dose-Response Relationship, Drug; | 2015 |
Neuroprotection by glutamate oxaloacetate transaminase in ischemic stroke: an experimental study.
Topics: Animals; Aspartate Aminotransferases; Brain; Brain Ischemia; Cells, Cultured; Endothelial Cells; Enz | 2011 |
Pyruvate protects glucose-deprived Müller cells from nitric oxide-induced oxidative stress by radical scavenging.
Topics: Adenosine Triphosphate; Animals; Animals, Newborn; Apoptosis; Brain Ischemia; Cells, Cultured; Energ | 2005 |